Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

Clinical Trials and Medical Trials

MedTrials.co.uk is a website that will put you in direct contact with Pharmaceutical Companies, CRO’s (Clinical Research Organisations) and Clinical Investigators that are running Phase I (1) and Phase II (2) clinical trials.

Medical trials are an integral part of the drug development process. Patient and volunteer participation is vital for continued medical research and these trials are carried out under strict regulations.

Register as a Clinical Trial volunteer.

View information about current Clinical Trials.

If at any point you feel that you have changed your mind and are no longer interested in undertaking a medical trial you can unsubscribe from our service. If you are already part way through a medical trial, speak to the Clinical Investigator and they will advise you of your options.

Clinical research companies often offer financial compensation for your time and expenses.

Clinical Trial Information

Register now for clinical trials

News

Rutgers Cancer Institute of New Jersey studying low participation in cancer screenings by South Asian population

In an effort to learn why South Asians in New Jersey and New York City have low participation rates when it comes to some cancer screenings, researchers at Rutgers Cancer Institute of New Jersey… Go to Source

more >

Merck announces data from pivotal Phase 3 fracture outcomes study for odanacatib, an investigational oral, once-weekly treatment for osteoporosis

Merck, known as MSD outside the United States and Canada, has announced data from the pivotal Phase 3 fracture outcomes study for odanacatib in postmenopausal women with osteoporosis. Go to Source

more >

New analyses of Phase 2 study show Romosozumab treatment resulted in continued increases in bone mineral density

UCB and Amgen have announced results from several exploratory analyses of the Phase 2 study evaluating romosozumab in postmenopausal women with low bone mineral density (BMD). Go to Source

more >

New data on the long-term efficacy and safety of Tresiba®  in children and adolescents with type 1 diabetes

During the 50th Annual Meeting of the European Association for the Study of Diabetes (EASD), Novo Nordisk announced new data from the BEGIN® YOUNG 1 trial. Go to Source

more >

Roche initiates phase III trials for lampalizumab, first potential treatment for geographic atrophy (GA)

Roche has announced that phase III clinical studies have been initiated for lampalizumab, an investigational drug for geographic atrophy (GA), the advanced form of age-related macular degeneration… Go to Source

more >

Large prospective randomized trial confirms clinical benefit of Embryoscope® time-lapse system

The success rate of assisted reproduction was significantly increased by the use of revolutionary time-lapse technologyA study accepted for publication in the renowned scientific journal… Go to Source

more >